The Defense Health Agency awarded Texas Christian University $633,788 on November 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) for a project titled "From Waste to UV Armor: Development and Optimization of Cost-Effective" with performance through October 31, 2029. The award is a Project Grant classified as assistance funding.
Work is performed at Fort Worth, Texas. The program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative research and investigation of medical solutions for battlefield applications. Award amounts under this program typically range from $100,000 to $20 million for consortium efforts, with average award periods of three to four years. Recipients are subject to pre-application coordination and a two-tier review process (peer review for technical merit, followed by programmatic review) conducted by DHA scientists, federal representatives, outside experts, clinicians, and consumers.